Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320492014> ?p ?o ?g. }
- W4320492014 endingPage "457" @default.
- W4320492014 startingPage "457" @default.
- W4320492014 abstract "Breast cancer is the most frequent malignant neoplastic disease in women, with an estimated 2.3 million cases in 2020 worldwide. Its treatment depends on characteristics of the patient and the tumor. In the latter, characteristics include cell type and morphology, anatomical location, and immunophenotype. Concerning this latter aspect, the overexpression of the HER2 receptor, expressed in 15-25% of tumors, is associated with greater aggressiveness and worse prognosis. In recent times some monoclonal antibodies have been developed in order to target HER2 receptor overexpression. Trastuzumab is part of the monoclonal antibodies used as targeted therapy against HER2 receptor, whose major problem is its cardiac safety profile, where it has been associated with cardiotoxicity. The appearance of cardiotoxicity is an indication to stop therapy. Although the pathophysiological mechanism is poorly known, evidence indicates that oxidative stress plays a fundamental role causing DNA damage, increased cytosolic and mitochondrial ROS production, changes in mitochondrial membrane potential, intracellular calcium dysregulation, and the consequent cell death through different pathways. The aim of this review was to explore the use of antioxidants as adjuvant therapy to trastuzumab to prevent its cardiac toxicity, thus leading to ameliorate its safety profile in its administration." @default.
- W4320492014 created "2023-02-14" @default.
- W4320492014 creator A5033901190 @default.
- W4320492014 creator A5039329214 @default.
- W4320492014 creator A5052506261 @default.
- W4320492014 creator A5065222117 @default.
- W4320492014 creator A5080008182 @default.
- W4320492014 creator A5023544888 @default.
- W4320492014 creator A5050486233 @default.
- W4320492014 date "2023-02-10" @default.
- W4320492014 modified "2023-09-30" @default.
- W4320492014 title "Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy" @default.
- W4320492014 cites W1662674303 @default.
- W4320492014 cites W1699432502 @default.
- W4320492014 cites W176993554 @default.
- W4320492014 cites W1772131958 @default.
- W4320492014 cites W1889928106 @default.
- W4320492014 cites W1911171695 @default.
- W4320492014 cites W1925211454 @default.
- W4320492014 cites W1968598018 @default.
- W4320492014 cites W1969345980 @default.
- W4320492014 cites W1981545668 @default.
- W4320492014 cites W1982729445 @default.
- W4320492014 cites W1983698019 @default.
- W4320492014 cites W2003490109 @default.
- W4320492014 cites W2005889240 @default.
- W4320492014 cites W2005967825 @default.
- W4320492014 cites W2014166418 @default.
- W4320492014 cites W2018896819 @default.
- W4320492014 cites W2020218285 @default.
- W4320492014 cites W2023695511 @default.
- W4320492014 cites W2024417353 @default.
- W4320492014 cites W2028945760 @default.
- W4320492014 cites W2029310513 @default.
- W4320492014 cites W2029542561 @default.
- W4320492014 cites W2030899725 @default.
- W4320492014 cites W2033766456 @default.
- W4320492014 cites W2036594293 @default.
- W4320492014 cites W2044864652 @default.
- W4320492014 cites W2050395878 @default.
- W4320492014 cites W2051449338 @default.
- W4320492014 cites W2060517558 @default.
- W4320492014 cites W2062289724 @default.
- W4320492014 cites W2082095383 @default.
- W4320492014 cites W2083386761 @default.
- W4320492014 cites W2099545363 @default.
- W4320492014 cites W2100381809 @default.
- W4320492014 cites W2101253730 @default.
- W4320492014 cites W2104272500 @default.
- W4320492014 cites W2112196039 @default.
- W4320492014 cites W2116120611 @default.
- W4320492014 cites W2125620887 @default.
- W4320492014 cites W2128402413 @default.
- W4320492014 cites W2131133480 @default.
- W4320492014 cites W2133105825 @default.
- W4320492014 cites W2138600064 @default.
- W4320492014 cites W2140525205 @default.
- W4320492014 cites W2144181696 @default.
- W4320492014 cites W2156936809 @default.
- W4320492014 cites W2159334325 @default.
- W4320492014 cites W2159427817 @default.
- W4320492014 cites W2160329331 @default.
- W4320492014 cites W2164109610 @default.
- W4320492014 cites W2167121370 @default.
- W4320492014 cites W2169281409 @default.
- W4320492014 cites W2277879584 @default.
- W4320492014 cites W2298838354 @default.
- W4320492014 cites W2318605753 @default.
- W4320492014 cites W2332644729 @default.
- W4320492014 cites W2342819511 @default.
- W4320492014 cites W2404013489 @default.
- W4320492014 cites W2460988556 @default.
- W4320492014 cites W2470078220 @default.
- W4320492014 cites W2558002415 @default.
- W4320492014 cites W2561345138 @default.
- W4320492014 cites W2565765808 @default.
- W4320492014 cites W2588881638 @default.
- W4320492014 cites W2599068909 @default.
- W4320492014 cites W2612155628 @default.
- W4320492014 cites W2617166306 @default.
- W4320492014 cites W2761586844 @default.
- W4320492014 cites W2792595526 @default.
- W4320492014 cites W2801988573 @default.
- W4320492014 cites W2903082653 @default.
- W4320492014 cites W2907056240 @default.
- W4320492014 cites W2912993657 @default.
- W4320492014 cites W2914134682 @default.
- W4320492014 cites W2931569406 @default.
- W4320492014 cites W2948656647 @default.
- W4320492014 cites W2977550664 @default.
- W4320492014 cites W2981236462 @default.
- W4320492014 cites W2982383998 @default.
- W4320492014 cites W2994816288 @default.
- W4320492014 cites W3005344633 @default.
- W4320492014 cites W3023614791 @default.
- W4320492014 cites W3023752815 @default.
- W4320492014 cites W3023854389 @default.
- W4320492014 cites W3025076282 @default.